Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 1614

Sort by

Sort Order Select

Journal Articles

Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation

Ramzi Abboud, Mark A. Schroeder, Michael P. Rettig, Reyka G. Jayasinghe, Feng Gao, Jeremy Eisele, Leah Gehrs, Julie Ritchey, Jaebok Choi, Camille N. Abboud, Iskra Pusic, Meagan Jacoby, Peter Westervelt, Matthew Christopher, Amanda Cashen, Armin Ghobadi, Keith Stockerl-Goldstein, Geoffrey L. Uy, John F. DiPersio

Blood (2025) 145 (13): 1382–1394.

https://doi.org/10.1182/blood.2024026497

Published: 2025

Includes: Supplemental data

Journal Articles

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement

Uma Borate, Kelly Pugh, Allyson Waller, Rina Li Welkie, Ying Huang, Jan Philipp Bewersdorf, Maximilian Stahl, Amy E. DeZern, Uwe Platzbecker, Mikkael A. Sekeres, Andrew H. Wei, Rena J. Buckstein, Gail J. Roboz, Michael R. Savona, Sanam Loghavi, Robert P. Hasserjian, Pierre Fenaux, David A. Sallman, Christopher S. Hourigan, Matteo Giovanni Della Porta, Stephen Nimer, Richard F. Little, Valeria Santini, Fabio Efficace, Justin Taylor, Guillermo Garcia-Manero, Olatoyosi Odenike, Tae Kon Kim, Stephanie Halene, Rami S. Komrokji, Elizabeth A. Griffiths, Peter L. Greenberg, Mina L. Xu, Zhuoer Xie, Rafael Bejar, Guillermo F. Sanz, Mrinal M. Patnaik, Maria Figueroa, Hetty E. Carraway, Omar Abdel-Wahab, Daniel Starczynowski, Eric Padron, Jacqueline Boultwood, Steven Gore, Naval G. Daver, Jane E. Churpek, Ravindra Majeti, John M. Bennett, Alan F. List, Andrew M. Brunner, Amer M. Zeidan

Blood (2025) 145 (13): 1369–1381.

https://doi.org/10.1182/blood.2023023717

Published: 2025

Includes: Supplemental data

Journal Articles

α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia

Scott E. Millman, Almudena Chaves-Perez, Sudha Janaki-Raman, Yu-Jui Ho, John P. Morris, IV, Varun Narendra, Chi-Chao Chen, Benjamin T. Jackson, Jossie J. Yashinskie, Riccardo Mezzadra, Tessa I. Devine, Valentin J. A. Barthet, Michelle Saoi, Timour Baslan, Sha Tian, Zohar Sachs, Lydia W. S. Finley, Justin R. Cross, Scott W. Lowe

Blood (2025) 145 (13): 1422–1436.

https://doi.org/10.1182/blood.2024025245

Published: 2025

Includes: Supplemental data

Journal Articles

Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE 2 signaling in NK cells

Blood (2025) 145 (13): 1395–1406.

https://doi.org/10.1182/blood.2024025706

Published: 2025

Includes: Supplemental data

Journal Articles

Atypical chronic myeloid leukemia: from cytology to molecular characterization

Aida Calo-Pérez, Raquel Martínez-Fernández

Blood (2025) 145 (13): 1438.

https://doi.org/10.1182/blood.2024027505

Published: 2025

Journal Articles

Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis

Blood blood.2024027287.

https://doi.org/10.1182/blood.2024027287

Published: 2025

Includes: Supplemental data

Journal Articles

How I treat chronic myeloid leukemia in children and adolescents

Jing Chen, Meinolf Suttorp, Nobuko Hijiya

Blood blood.2024026514.

https://doi.org/10.1182/blood.2024026514

Published: 2025

Journal Articles

How I treat acute myeloid leukemia with differentiation therapy

Ghayas C. Issa, Eytan M. Stein, Courtney D. DiNardo

Blood (2025) 145 (12): 1251–1259.

https://doi.org/10.1182/blood.2024024008

Published: 2025

Journal Articles

How I treat secondary acute myeloid leukemia

Steven D. Green, Eunice S. Wang

Blood (2025) 145 (12): 1260–1272.

https://doi.org/10.1182/blood.2024024011

Published: 2025

Journal Articles

How I use maintenance therapy in acute myeloid leukemia

Gail J. Roboz, Jonathan Canaani

Blood (2025) 145 (12): 1273–1281.

https://doi.org/10.1182/blood.2024024010

Published: 2025

Journal Articles

How I treat patients with AML using azacitidine and venetoclax

Andrew H. Wei, Sun Loo, Naval Daver

Blood (2025) 145 (12): 1237–1250.

https://doi.org/10.1182/blood.2024024009

Published: 2025

Includes: Supplemental data

Journal Articles

Introduction to a How I Treat series on acute myeloid leukemia

Selina M. Luger

Blood (2025) 145 (12): 1227–1228.

https://doi.org/10.1182/blood.2024027264

Published: 2025

Journal Articles

Megakaryocyte mitotic figures in de novo AML, myelodysplasia related, with STAG2, SRSF2, and ASXL1 comutations

Zhaodong Xu, Kristine Roland

Blood (2025) 145 (12): 1333.

https://doi.org/10.1182/blood.2024027590

Published: 2025

Journal Articles

PI3Kγ in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target

Qingyu Luo, Amanda L. Fortune, Andrew A. Lane

Blood blood.2024027376.

https://doi.org/10.1182/blood.2024027376

Published: 2025

Journal Articles

Considerations on the Dose and Schedule of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Does Dose Matter?

Mark Dalgetty, Jorge Cortes

Blood blood.2024027944.

https://doi.org/10.1182/blood.2024027944

Published: 2025

Journal Articles

Honing CAR T cells to tackle acute myeloid leukemia

Sascha Haubner, Marion Subklewe, Michel Sadelain

Blood (2025) 145 (11): 1113–1125.

https://doi.org/10.1182/blood.2024024063

Published: 2025

Journal Articles

Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes

Jacqueline S. Garcia, Uwe Platzbecker, Olatoyosi Odenike, Shaun Fleming, Chun Yew Fong, Uma Borate, Meagan A. Jacoby, Daniel Nowak, Maria R. Baer, Pierre Peterlin, Brenda Chyla, Huipei Wang, Grace Ku, David Hoffman, Jalaja Potluri, Guillermo Garcia-Manero

Blood (2025) 145 (11): 1126–1135.

https://doi.org/10.1182/blood.2024025464

Published: 2025

Includes: Supplemental data

Journal Articles

Single-cell epigenetic and clonal analysis decodes disease progression in pediatric acute myeloid leukemia

Boyu Cui, Lanlan Ai, Minghui Lei, Yongjuan Duan, Chao Tang, Jingliao Zhang, Yan Gao, Xuan Li, Caiying Zhu, Yingchi Zhang, Xiaofan Zhu, Tomoya Isobe, Wenyu Yang, Berthold Göttgens, Ping Zhu

Blood (2025) 145 (11): 1211–1224.

https://doi.org/10.1182/blood.2024025618

Published: 2025

Includes: Supplemental data

Journal Articles

Acute myeloid leukemia with RUNX1 :: CBFA2T3 fusion

Wei J. Wang, Sanam Loghavi

Blood (2025) 145 (11): 1226.

https://doi.org/10.1182/blood.2024027698

Published: 2025

Journal Articles

101(8)3126 Hu (Lichtenstein) retraction

Production Staff

Blood blood.2025029190.

https://doi.org/10.1182/blood.2025029190

Published: 2025

NARROW

Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement

α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia

Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE 2 signaling in NK cells

Atypical chronic myeloid leukemia: from cytology to molecular characterization

Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis

How I treat chronic myeloid leukemia in children and adolescents

How I treat acute myeloid leukemia with differentiation therapy

How I treat secondary acute myeloid leukemia

How I use maintenance therapy in acute myeloid leukemia

How I treat patients with AML using azacitidine and venetoclax

Introduction to a How I Treat series on acute myeloid leukemia

Megakaryocyte mitotic figures in de novo AML, myelodysplasia related, with STAG2, SRSF2, and ASXL1 comutations

PI3Kγ in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target

Considerations on the Dose and Schedule of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Does Dose Matter?

Honing CAR T cells to tackle acute myeloid leukemia

Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes

Single-cell epigenetic and clonal analysis decodes disease progression in pediatric acute myeloid leukemia

Acute myeloid leukemia with RUNX1 :: CBFA2T3 fusion

101(8)3126 Hu (Lichtenstein) retraction

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only